These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11835369)

  • 1. Challenging assumptions about Alzheimer's disease: mild cognitive impairment and the cholinergic hypothesis.
    Morris JC
    Ann Neurol; 2002 Feb; 51(2):143-4. PubMed ID: 11835369
    [No Abstract]   [Full Text] [Related]  

  • 2. Mild cognitive impairment and the cholinergic hypothesis: a very different take on recent data.
    Sarter M; Bruno JP
    Ann Neurol; 2002 Sep; 52(3):384-5. PubMed ID: 12205659
    [No Abstract]   [Full Text] [Related]  

  • 3. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.
    DeKosky ST; Ikonomovic MD; Styren SD; Beckett L; Wisniewski S; Bennett DA; Cochran EJ; Kordower JH; Mufson EJ
    Ann Neurol; 2002 Feb; 51(2):145-55. PubMed ID: 11835370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic markers in the cortex and hippocampus of some animal species and their correlation to Alzheimer's disease.
    Orta-Salazar E; Cuellar-Lemus CA; Díaz-Cintra S; Feria-Velasco AI
    Neurologia; 2014 Oct; 29(8):497-503. PubMed ID: 23433740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.
    Francis PT; Palmer AM; Sims NR; Bowen DM; Davison AN; Esiri MM; Neary D; Snowden JS; Wilcock GK
    N Engl J Med; 1985 Jul; 313(1):7-11. PubMed ID: 2582256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer's disease.
    Foley P; Bradford HF; Docherty M; Fillit H; Luine VN; McEwen B; Bucht G; Winblad B; Hardy J
    J Neurol; 1988 Nov; 235(8):466-71. PubMed ID: 3210051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic markers in the early diagnosis of Alzheimer's disease.
    Jenden DJ
    Bull Clin Neurosci; 1985; 50():49-52. PubMed ID: 3915951
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholecystokinin protects cholinergic neurons against basal forebrain lesion.
    Sugaya K; Takahashi M; Kubota K
    Jpn J Pharmacol; 1992 May; 59(1):125-8. PubMed ID: 1507652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease.
    Mufson EJ; Ikonomovic MD; Styren SD; Counts SE; Wuu J; Leurgans S; Bennett DA; Cochran EJ; DeKosky ST
    Arch Neurol; 2003 Aug; 60(8):1143-8. PubMed ID: 12925373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease.
    Rinne JO; Lönnberg P; Marjamäki P; Rinne UK
    Brain Res; 1989 Apr; 483(2):402-6. PubMed ID: 2706531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the loss of cerebral cortical choline acetyl transferase activity in Alzheimer's disease due to degeneration of ascending cholinergic nerve cells.
    Mann DM; Yates PO
    J Neurol Neurosurg Psychiatry; 1982 Oct; 45(10):936. PubMed ID: 7143014
    [No Abstract]   [Full Text] [Related]  

  • 12. The cholinergic system and the excitatory amino acids in Alzheimer's disease.
    Bowen D
    Acta Neurol Scand Suppl; 1990; 129():15-6. PubMed ID: 2220318
    [No Abstract]   [Full Text] [Related]  

  • 13. Somatostatin alterations and brain diseases.
    Epelbaum J; Agid Y; Enjalbert A; Hamon M; Javoy-Agid F; Kordon C; Lamour Y; Moyse E
    Adv Exp Med Biol; 1985; 188():261-74. PubMed ID: 2863935
    [No Abstract]   [Full Text] [Related]  

  • 14. Human striatal cholinergic neurons in development, aging and Alzheimer's disease.
    Geula C; Tokuno H; Hersh L; Mesulam MM
    Brain Res; 1990 Feb; 508(2):310-2. PubMed ID: 2306623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha triggers cell death of sensitized potassium chloride-stimulated cholinergic neurons.
    Zassler B; Weis C; Humpel C
    Brain Res Mol Brain Res; 2003 May; 113(1-2):78-85. PubMed ID: 12750009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential responsivity of mood, behavior, and cognition to cholinergic agents in elderly neuropsychiatric populations.
    Sunderland T; Tariot PN; Newhouse PA
    Brain Res; 1988 Dec; 472(4):371-89. PubMed ID: 3066441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data.
    Liberini P
    Funct Neurol; 1997; 12(3-4):153-7. PubMed ID: 9218969
    [No Abstract]   [Full Text] [Related]  

  • 18. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.
    Candy JM; Perry EK; Perry RH; Court JA; Oakley AE; Edwardson JA
    Prog Brain Res; 1986; 70():105-32. PubMed ID: 3554348
    [No Abstract]   [Full Text] [Related]  

  • 19. The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease.
    Cummings JL; Back C
    Am J Geriatr Psychiatry; 1998; 6(2 Suppl 1):S64-78. PubMed ID: 9581223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional cholinergic denervation of cortical microvessels and nitric oxide synthase-containing neurons in Alzheimer's disease.
    Tong XK; Hamel E
    Neuroscience; 1999; 92(1):163-75. PubMed ID: 10392839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.